AnalystsLisa WalterLisa Walter's Stock Forecasts
AnalystsLisa Walter
Sectors:
Industries:
Analyst Ranking
Top 32%
#1642 out of 5156 analysts
Average Return
+27.52%
Win Rate
67%6 out of 9
Risk vs Reward
Poor
Good
Lisa Walter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viridian Therapeutics IncVRDN | +94.37% | $16.53 | $32.13 | 2025-08-06 - 2025-12-17 | Buy |
Eyepoint Pharmaceuticals IncEYPT | +89.10% | $8.81 | $16.66 | 2025-06-16 - 2025-12-17 | Buy |
Eyepoint Pharmaceuticals IncEYPT | +50.36% | $11.08 | $16.66 | 2025-11-05 - 2025-12-17 | Buy |
United Therapeutics CorpUTHR | +18.09% | $432.66 | $510.94 | 2025-09-25 - 2025-12-17 | Buy |
Viridian Therapeutics IncVRDN | +16.84% | $27.50 | $32.13 | 2025-11-05 - 2025-12-17 | Buy |
Lisa Walter Analyst Color
Get additional color on Lisa Walter's coverage of popular stocks
Lisa Walter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Meiragtx Holdings PLCMGTX | 1 | Buy | $16.00 | +97.29% | Maintains | a month ago |
4d Molecular Therapeutics IncFDMT | 2 | Buy | $32.00 | +247.45% | Maintains | a month ago |
Viridian Therapeutics IncVRDN | 2 | Buy | $45.00 | +40.06% | Maintains | a month ago |
Eyepoint Pharmaceuticals IncEYPT | 2 | Buy | $39.00 | +134.09% | Maintains | a month ago |
United Therapeutics CorpUTHR | 2 | Buy | $587.00 | +14.89% | Maintains | 2 months ago |
Adverum Biotechnologies IncADVM | 1 | Hold | $4.00 | -8.26% | Maintains | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 1 | Hold | $19.00 | -24.60% | Maintains | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.